Kyle Y. Faget | People | McDermott Skip to main content

Überblick


Kyle Y. Faget advises a diverse client base – including life sciences companies, digital health platforms, virtual care providers, and academic medical centers – on regulatory, transactional, and compliance matters, with a focus on software as a medical device and artificial intelligence (AI) applications in healthcare. She has extensive experience in developing corporate compliance programs and regulatory strategies and provides guidance on US Food and Drug Administration (FDA) regulations for both established products and emerging technologies, including AI-enabled solutions.

Mehr anzeigen

Auszeichnungen


  • JD Supra, Reader’s Choice Awards, Top Author – Life Sciences, 2024
  • The Best Lawyers in America®, Biotechnology and Life Sciences, Health Care Law, 2023-2024
  • Chambers USA, America’s Leading Lawyers for Business, Healthcare: 2021, 2023-2025, Life Sciences: 2025
  • Massachusetts Super Lawyers®, Rising Star, 2018-2019

Mitgliedschaften


  • American Health Lawyers Association, member
  • American Bar Foundation, fellow
  • Fenway Health, board of directors
  • Lexis Practical Guidance Life Sciences Advisory, board member

Qualifikation


Education
University of Michigan Law School, JD, 2007
Bryn Mawr College, Certificate in Post-Baccalaureate Pre-Medical Studies, 2002
Smith College, AB, 1997

Admissions
Massachusetts